|
⚲
|
| Keyboard |
| Willard Stephen H
✚
|
|
|---|---|
| CIK # | 0001325232 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001325232] | |
| 4 | [0001325232] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Longeveron LLC | |
| Willard Stephen H | |
| NRX Pharmaceuticals Inc | |
| E Trade Financial Corp |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Longeveron LLC LGVN
Class A Common Stock
|
2026-03-02 | Grant | 200,000 | $0.00 | |
|
Longeveron LLC LGVN
Class A Common Stock
|
2026-03-02 | Grant | 200,000 | $0.00 | |
|
Longeveron LLC LGVN
Class A Common Stock
|
2026-03-02 | Tax withheld | 105,533 | $0.55 | 58,043 |
|
Longeveron LLC LGVN
Stock Option (right to buy) · derivative
|
2026-03-02 | Grant | 200,000 | $0.00 | |
|
NRX Pharmaceuticals Inc NRXP
Common Stock, par value $0.001 per share
|
2022-12-16 | Buy | 50,000 | $1.17 | 58,500 |
|
E Trade Financial Corp ETFC
Common Stock
|
2013-05-09 | Grant | 4,575 | $0.00 | |
|
E Trade Financial Corp ETFC
Common Stock
|
2012-05-10 | Grant | 5,154 | $0.00 |